A suppressor tRNA Tyr and mutant tyrosyl-tRNA synthetase (TyrRS) pair was developed to incorporate 3-iodo-L-tyrosine into proteins in mammalian cells. First, the Escherichia coli suppressor tRNA Tyr gene was mutated, at three positions in the D arm, to generate the internal promoter for expression. However, this tRNA, together with the cognate TyrRS, failed to exhibit suppressor activity in mammalian cells. Then, we found that amber suppression can occur with the heterologous pair of E.coli TyrRS and Bacillus stearothermophilus suppressor tRNA Tyr , which naturally contains the promoter sequence. Furthermore, the ef®ciency of this suppression was signi®cantly improved when the suppressor tRNA was expressed from a gene cluster, in which the tRNA gene was tandemly repeated nine times in the same direction. For incorporation of 3-iodo-L-tyrosine, its speci®c E.coli TyrRS variant, TyrRS(V37C195), which we recently created, was expressed in mammalian cells, together with the B.stearothermophilus suppressor tRNA Tyr , while 3-iodo-L-tyrosine was supplied in the growth medium. 3-Iodo-L-tyrosine was thus incorporated into the proteins at amber positions, with an occupancy of >95%. Finally, we demonstrated conditional 3-iodo-L-tyrosine incorporation, regulated by inducible expression of the TyrRS(V37C195) gene from a tetracycline-regulated promoter.
INTRODUCTION
The incorporation of unnatural chemical groups into proteins has increasing importance in protein science and cell biology. Biophysical probes or structural modi®cations have been introduced into proteins by chemical modi®cations of amino acid residues (1) or by semi-synthetic methods involving protein ligations (2) . The biosynthesis of proteins containing unnatural amino acids, alloproteins (3) , is also a promising way of expanding the structural and chemical diversity in proteins (3±11). The site-speci®c incorporation of unnatural amino acids has been employed to study membrane proteins expressed in Xenopus oocytes (6, 7) . The utility of`sitespeci®c alloproteins' for regulating the interactions between cell signaling proteins has been shown in experiments in vitro (12) . However, the only eukaryotic in vivo system available for alloprotein synthesis has been con®ned to Xenopus oocytes, which has severely limited the yields of alloproteins (7) . The availability of alloproteins in mammalian cells should be extended for further applications in cell biology.
Unnatural amino acids have been attached to the speci®c adaptor tRNAs corresponding to amber codons (4, 10, 11) , four base codons (13) or arti®cial codons with unnatural bases (14, 15) . One approach for site-speci®c-alloprotein synthesis involves the synthesis of the aminoacylated forms of the tRNAs, by chemical acylation (16) or by using an aminoacyltRNA synthetase (aaRS) (8, 15) , before their use in alloprotein synthesis. The adaptor tRNA cannot be reacylated during translation without the speci®c aaRS for the unnatural amino acid. The use of the tRNA in the aminoacylated form is prohibitive to the large-scale synthesis of alloproteins in vitro or in vivo, or to the conditional incorporation of unnatural amino acids regulated by certain signals, such as a signal for the expression of the speci®c tRNA and/or aaRS.
Another approach involves the use of speci®c tRNA´aaRS pairs for the unnatural amino acids, allowing the reacylation of the tRNA. Wang et al. have created two variants of Methanococcus jannaschii tyrosyl-tRNA synthetase (TyrRS) that are highly speci®c to O-methyl-L-tyrosine (17) and L-3-(2-naphthyl)alanine (18) . When these amino acids were supplied in the growth medium, they were actually incorporated at amber positions by these variant enzymes and the cognate suppressor tRNA Tyr in Escherichia coli cells. The M.jannaschii TyrRS does not recognize E.coli tRNAs, while the E.coli aaRSs do not recognize the suppressor tRNA Tyr (17) . Thus, this archaebacterial tRNA Tyr´T yrRS pair is orthogonal' to the E.coli translation system.
To extend this approach to eukaryotic systems, we recently created a 3-iodo-L-tyrosine-speci®c variant of E.coli TyrRS, with the two amino acid replacements Y37V and Q195C (19) . This variant enzyme, TyrRS(V37C195), together with the E.coli suppressor tRNA Tyr , incorporates 3-iodo-L-tyrosine at amber positions in a wheatgerm cell-free translation (19) . To use this system in a mammalian cell, the E.coli TyrRS and the cognate suppressor tRNA Tyr should be expressed and functional in the cell.
The pair of a suppressor tRNA Gln and glutaminyl-tRNA synthetase (GlnRS) from E.coli, which is orthogonal to the eukaryotic translation system, has been expressed in mammalian cells and caused amber suppression (20) . The cytidine at position 9 (C9) in this tRNA was replaced by A to generate the internal promoter for expression in mammalian cells. On the other hand, the corresponding engineering for the E.coli tRNA Tyr would require three base substitutions in the positions involved in the tertiary interactions that support the L-shaped structure, which could impair tRNA function. This dif®culty has been circumvented by importing the aminoacylated form of this suppressor tRNA Tyr , with no such substitutions, into mammalian cells (21) .
In the present study, the Bacillus stearothermophilus suppressor tRNA Tyr was expressed in mammalian cells together with E.coli TyrRS(V37C195), for the incorporation of 3-iodo-L-tyrosine into proteins (Fig. 1) ; the Bacillus tRNA Tyr contains the internal promoters in its native sequence (Fig. 2) , and can be recognized by E.coli TyrRS (22) . Finally, we created a cell line that stably maintains this variant TyrRS gene expressed from a tetracycline-regulated promoter, for conditional incorporation of 3-iodo-L-tyrosine in the presence of this inducer.
MATERIALS AND METHODS

tRNA genes for the expression in mammalian cells
The human, E.coli and B.stearothermophilus suppressor tRNA Tyr genes were constructed by annealing two oligodeoxynucleotides, commercially synthesized by Amersham Pharmacia Biotech; each gene consists of the corresponding tRNA sequence, lacking the 3¢-CCA, and the 5¢-¯anking sequence (AGCGCTCCGGTTTTTCTGTGCTGAACCTCA-GGGGACGCCGACACACGTACACGTC) of the human tRNA Tyr gene (23) , linked to the 5¢ end of the tRNA sequence. These genes were each cloned within the EcoRI and HindIII sites of pBR322. The gene cluster consisting of nine unidirectional copies of the B.stearothermophilus suppressor tRNA Tyr gene was constructed by the following two steps (Fig. 3) . First, three PCRs, each with distinct sets of primers, were performed, using a GeneAmp PCR system 9700 (Applied Biosystems). The ®rst reaction produced a primerbinding site (pbs1) at one end, upstream of the gene, and a BstXI site, CCAGCAGACTGG (designated BstXI-1), at the other end, downstream of the gene. The second reaction produced the BstXI-1 site and another type of BstXI site, CCAGCTTCCTGG (BstXI-2), at the`upstream' and`downstream' ends, respectively, while the third reaction produced the BstXI-2 site (upstream) and the other primer-binding site, pbs2 (downstream). These PCR products were ligated with each other to generate a sub-cluster consisting of three copies of the tRNA gene. This sub-cluster was ampli®ed with the primers for pbs1 and pbs2, each with an additional sequence for a restriction site, to generate EcoRI and HindIII sites at thè pbs1' and`pbs2' ends, respectively. The HindIII±EcoRI and EcoRI±BamHI sites, each in the order of the pbs1 to pbs2 ends, were also generated similarly. Thus, three types of the subcluster with different combinations of the restriction sites were ®nally produced. These sub-clusters were cloned together within the EcoRI and BamHI sites of pBR322 to generate a plasmid carrying nine copies of the Bacillus suppressor tRNA Tyr gene.
Construction of TyrRS genes and reporter genes
The FLAG tag (DYKDDDDK) was added to the C-termini of the wild-type TyrRS and TyrRS(V37C195) genes, the ras gene and the epidermal growth factor receptor gene (24) by amplifying these genes with appropriate PCR primers. The Figure 1 . The mammalian cell system for incorporating 3-iodo-L-tyrosine into proteins in response to amber codons. 3-Iodo-L-tyrosine (IY), present together with L-tyrosine (Y) in the growth medium, is taken up into the cell and is then attached, by its speci®c E.coli mutant TyrRS, to the B.stearothermophilus (B. s.) suppressor tRNA Tyr . This tRNA carries this unnatural amino acid to the amber codon on the mRNA and incorporates it into a protein (alloprotein). On the other hand, the endogenous, mammalian tRNA Tyr´T yrRS pair incorporates L-tyrosine into the proteins at the corresponding tyrosine codon.
PCR products were each cloned into the vector pcDNA3.1/ Zeo(+) (Invitrogen) for expression in mammalian cells. For TyrRS(V37C195), the PCR product was also cloned into the vector pcDNA4/TO (Invitrogen) to generate plasmid pEYSM1 for tetracycline-regulated expression. The sitedirected mutagenesis of the ras gene was performed by PCR with mutagenic primers. Similarly, the tyrosine codon in position 1068 of the epidermal growth factor receptor was mutated to an amber codon. For the gene encoding a green uorescent protein (the cyano-¯uorescent variant) (Clontech), the ®rst methionine residue was replaced by a short peptide, encoded by ATGGGAACTAGTCCATAGTGGTGGAAT-TCTGCAGATATCCAGCACAGTGGCGGCCGCGTC (the amber codon is underlined) and the FLAG tag was added to the C-terminus. The resulting gene was cloned into the vector pcDNA3.1/Zeo(+). The sequences of the constructed genes were con®rmed using an ABI PRISM 377 DNA sequencer (Applied Biosystems).
Amber suppressions in mammalian cells
Transfections were carried out with 0.5±2 mg of DNA for each plasmid per 35 mm plate, according to the procedure for LipofectAMINE 2000 (Gibco BRL). Opti-MEM I (Gibco BRL) was used as the growth medium. Cell extracts were prepared 24 h after the transfection and were subjected to SDS±PAGE, followed by western blotting using the anti-FLAG M2 antibody (Sigma) and the ECL+ immunodetection system (Amersham Pharmacia Biotech). The band intensity was measured using an image analyzer, LAS-1000plus (Fuji Photo Film Co., Japan). The ras and ras(Am) products (0.5 mg each) were puri®ed, using an anti-FLAG M2 antibody af®nity gel (Sigma), from one and ®ve culture plates (100 mm diameter), respectively. The LC-MS analysis and the tandem mass spectrometry sequencing were performed as previously described (15) .
The CHO-Y cells
To create the CHO-Y cells, which stably maintain the TyrRS(V37C195) gene, T-REX-CHO cells (Invitrogen), constitutively producing the tetracycline repressor protein, were transfected with the plasmid pEYSM1. The transfectants were selected in growth medium containing 25 mg/ml Zeocin (Invitrogen) and the selected cells were examined for expression of TyrRS(V37C195) in the presence of 1 mg/ml tetracycline, to obtain the CHO-Y cells. For alloprotein synthesis, CHO-Y cells were transfected with the plasmids containing the ras(Am) and Bacillus suppressor tRNA Tyr genes. Tetracycline (1 mg/ml) and 3-iodo-L-tyrosine (0.3 mM) were added to the medium 24 h after transfection and the cell extracts were prepared after a further 24 h.
RESULTS
Amber suppression in mammalian cells dependent on the expression of a prokaryotic tRNA Tyr´T yrRS pair
The expression of tRNA in eukaryotic cells requires two internal promoters (boxes A and B) in the tRNA-encoding sequence (25) . Since the E.coli tRNA Tyr sequence contains only box B, U9 and C10 were replaced by A and G, respectively, to generate box A (Fig. 2) . The resulting mismatched base pair, G10´G25, was repaired by the substitution G25C. Positions 9, 10 and 25 are involved in the tertiary interactions supporting the L-shaped structure, but are not involved in the identity of E.coli tRNA Tyr (26) . The sequence of tRNA Tyr (A9G10C25) with a CUA anticodon was linked to the 5¢-¯anking sequence of the human tRNA Tyr gene. The human suppressor tRNA Tyr gene was similarly constructed as a control of amber suppression. To analyze the amber suppression, the tyrosine codon in position 32 in a truncated, synthetic ras gene (27) for the wild-type c-Ha-Ras was mutated to an amber codon. To detect expression, a FLAG peptide tag was added to the C-termini of the ras gene, ras(WT), and its amber derivative, ras(Am), as well as to the C-termini of the E.coli TyrRSs.
These ras genes were introduced into CHO cells and their products were detected by western blotting of the cell extracts with an anti-FLAG antibody (Fig. 4A ). In the absence of the suppressor tRNAs, expression of the ras(WT) gene was detected (lane 1), whereas that of ras(Am) was not detected (lane 2), indicating the lack of an intrinsic suppressor activity within the cell. The human suppressor tRNA Tyr suppressed the amber mutation in ras(Am), with an ef®ciency of 26%, as determined by the band intensity (lane 3). On the other hand, the E.coli tRNA Tyr (A9G10C25) with a CUA anticodon, together with the wild-type TyrRS from E.coli, did not cause suppression (lane 4). Then, we tested another E.coli suppressor tRNA Tyr variant, with the other possible set of nucleotides to generate box A (G9G10C25); this tRNA also failed to cause suppression (data not shown). Thus, the generation of box A in the E.coli suppressor tRNA Tyr impaired suppression activity, probably through a distortion in the tertiary structure, which may lead to inhibition of the maturation or the aminoacylation of the tRNA.
It has been reported that B.stearothermophilus tRNA Tyr can be aminoacylated by E.coli TyrRS (22) , although this Bacillus tRNA Tyr has a different set of nucleotides from that in E.coli tRNA Tyr , in the positions involved in the tertiary interactions, and thus contains both boxes A and B (Fig. 2) . We found that co-expression of the B.stearothermophilus suppressor tRNA and the E.coli TyrRS suppressed the amber mutation in ras(Am) with an ef®ciency of 15% (Fig. 4A, lane 5 
The suppression ef®ciency for this heterologous pair of tRNA Tyr´T yrRS was signi®cantly lower than the ef®ciency for the human suppressor tRNA Tyr or the ef®ciencies for other suppressor tRNAs working in mammalian cells (20± 40%) (28, 29) . Since the suppression ef®ciency can be improved by increasing the dose of the suppressor tRNA gene (30), a plasmid carrying nine copies of the Bacillus suppressor tRNA Tyr gene was constructed and was introduced into the CHO cells together with the plasmid carrying the E.coli TyrRS gene. The suppression ef®ciency was thus improved up to 24% (Fig. 4A, lane 8) , a value comparable to that for the human suppressor tRNA Tyr . Hereafter, we used this plasmid for expression of the Bacillus suppressor tRNA Tyr .
The pair of the Bacillus suppressor tRNA Tyr and the E.coli TyrRS also suppressed the amber mutation in human embryonic kidney 293 cells, with an ef®ciency similar to that Figure 3 . Construction of a plasmid carrying nine tandem copies of the B.stearothermophilus suppressor tRNA Tyr . Three copies of this suppressor tRNA Tyr gene, represented by the arrow, were assembled, by ligation at the BstXI sites (BstXI-1 and BstXI-2), into a sub-cluster with the primer-binding sites (pbs1 and pbs2) at the ends. Three copies of this sub-cluster, each with the EcoRI (E), HindIII (H) or BamHI (B) sites, were then assembled and cloned within the EcoRI±BamHI sites of pBR322. 1 and 3) and the wild-type EGFR gene (lane 2), each with a FLAG tag, were introduced into CHO cells. The B.stearothermophilus suppressor tRNA Tyr and the E.coli TyrRS pair were expressed in the cells (lane 3). The faint band migrating at the level of the E.coli TyrRS (lanes 1 and 2) was due to endogenous proteins that respond to the anti-FLAG antibody.
in the CHO cells (data not shown). Furthermore, an amber mutation in the epidermal growth factor receptor gene was suppressed with an ef®ciency of 20% (Fig. 4B) , while an amber mutation in the Aequorea victoria green¯uorescent protein gene was also suppressed with similar ef®ciency (data not shown). These genes and the ras(Am) gene have different codon contexts around the amber codon.
3-Iodo-L-tyrosine incorporation in response to an amber codon
For 3-iodo-L-tyrosine incorporation into proteins, we considered the following two points. First, mammalian cells have the transport machinery to assimilate canonical amino acids, as well as a variety of their analogs, from the environment (31) . Second, the wild-type TyrRSs from eukaryotes and prokaryotes do not recognize 3-iodo-L-tyrosine as a substrate (32±34). Therefore, 3-iodo-L-tyrosine probably has no toxicity caused by its misincorporation at tyrosine positions, while a variant TyrRS that can recognize 3-iodo-L-tyrosine is necessary for its attachment to the suppressor tRNA.
We employed E.coli TyrRS(V37C195), which has been reported to recognize 3-iodo-L-tyrosine ef®ciently (the k cat /K m value for amino acid activation is 3.3 Q 10 3 /M/s) and L-tyrosine 10-fold less ef®ciently (the k cat /K m is 3.2 Q 10 2 /M/s) (19) . Furthermore, TyrRS(V37C195) activates L-tyrosine 10 000-fold less ef®ciently, as compared with the k cat /K m value (2.3 Q 10 6 /M/s) for the wild-type enzyme. The wild-type TyrRS and TyrRS(V37C195) were each expressed in CHO cells, together with the Bacillus suppressor tRNA Tyr and the ras(Am) gene. These enzymes were expressed at similar levels ( Fig. 5A and B) . In the absence of 3-iodo-Ltyrosine (Fig. 5A) , amber suppression was observed for both enzymes, although the yield of the ras(Am) products for TyrRS(V37C195) was only 40% of that for the wild-type enzyme. This indicates that, in the absence of competing 3-iodo-L-tyrosine, TyrRS(V37C195) still recognizes L-tyrosine and incorporates it into the amber position. 3-Iodo-Ltyrosine was then added, to a ®nal concentration of 0.3 mM, in the growth medium, which contained L-tyrosine at a 2-fold higher concentration (Fig. 5B ). This concentration of 3-iodo-L-tyrosine had no apparent effect on cell growth. In the presence of 3-iodo-L-tyrosine, the suppression ef®ciency for TyrRS(V37C195) was improved to a level comparable to that for the wild-type enzyme, suggesting that 3-iodo-L-tyrosine was ef®ciently taken up by the cell and was incorporated into the protein through recognition by TyrRS(V37C195).
To con®rm 3-iodo-L-tyrosine incorporation and to determine its occupancy at the amber position (position 32), the ras(Am) and ras(WT) products were analyzed by LC-MS. These ras products were each synthesized in CHO cells expressing the Bacillus suppressor tRNA Tyr and TyrRS-(V37C195) in the presence of 3-iodo-L-tyrosine. The puri®ed Ras proteins were digested with Achromobacter protease I (Lys-C) and the produced fragments were separated from each other by liquid chromatography (Fig. 6A) . The amino acids incorporated at position 32 were analyzed in the mass chromatograms, each for a speci®c average mass, along with the liquid chromatography retention time. Two fragments, each corresponding to the region from Ser17 to Lys42, contained iodotyrosine and tyrosine at position 32 (designated the IY and Y fragments, respectively).
In the analysis of the ras(Am) products, the IY fragment was strongly observed (Fig. 6B, chart a) , indicating ef®cient incorporation of 3-iodo-L-tyrosine. The partial sequence of this IY fragment, determined by tandem mass spectrometry, con®rmed that iodotyrosine was actually incorporated at position 32 (Fig. 6C) . On the other hand, no Y fragment was detected (Fig. 6B, chart b) , indicating that 3-iodo-L-tyrosine inhibited the incorporation of L-tyrosine at position 32. Further analysis of the LC-MS data showed that no other canonical amino acids were incorporated at this position (data not shown). The occupancy of iodotyrosine at position 32 was thus estimated to be >95% by the present LC-MS analysis. In contrast, for the ras(WT) products synthesized in the presence of 3-iodo-L-tyrosine, the IY fragment was not observed (Fig. 6 , chart c), with the expected detection of the Y fragment (chart d). This demonstrates that the endogenous TyrRS in the CHO cell does not recognize 3-iodo-L-tyrosine and TyrRS(V37C195) does not recognize the endogenous tRNA Tyr , because either misrecognition would incorporate 3-iodo-L-tyrosine in place of tyrosine.
Conditional incorporation of 3-iodo-L-tyrosine regulated by inducible expression of the variant TyrRS
Escherichia coli GlnRS has been expressed in mammalian cells, from a tetracycline-regulated promoter, for induced suppression (35) . We created a CHO cell line that stably maintains the TyrRS(V37C195) gene expressed from another type of tetracycline-regulated promoter (designated CHO-YS cells). The ras(Am) gene and the Bacillus suppressor tRNA Tyr gene were then transiently introduced into the CHO-YS cells. TyrRS(V37C195) was expressed when tetracycline was present in the growth medium (Fig. 7, lanes 1 and 2) , but was not expressed without the inducer (lane 3). The expression level was twice the level for TyrRS(V37C195) that was expressed from the plasmid transiently introduced into the cells. The ras(Am) products were detected in the presence of both 3-iodo-L-tyrosine and tetracycline, with a suppression ef®ciency of 30% (lane 1). The quality of the ras(Am) products, as well as that of ras(WT) produced similarly in CHO-Y cells, was analyzed by LC-MS and was thus shown to be identical to their quality under TyrRS(V37C195) expression from the plasmid; >95% of the ras(Am) products contained 3-iodo-L-tyrosine at the amber position, while 3-iodo-L-tyrosine was not detected in the ras(WT) products (data not shown).
On the other hand, the ras(Am) products were hardly detected in the absence of 3-iodo-L-tyrosine (lane 2) and were not detected in the absence of the inducer (lane 3). These observations showed that tetracycline effectively conditioned 3-iodo-L-tyrosine incorporation into the ras(Am) product through induction of TyrRS(V37C195) expression. A comparison of Figure 7 with Figure 5A shows that L-tyrosine incorporation in the absence of 3-iodo-L-tyrosine was signi®-cantly lower than that for the case that TyrRS(V37C195) was expressed from the plasmid. This had not been expected, and was observed in more than three independent experiments. The molecular mechanism underlying this phenomenon is a subject of further study.
DISCUSSION
It has been shown that an amber suppressor derived from E.coli tRNA Gln can function in mammalian cell, in the presence of its cognate enzyme (20, 35) . The dif®culty of extending this approach to other tRNA´aaRS systems is that many prokaryotic tRNAs do not contain the complete promoter for their expression in eukaryotes. Although some of the residues in the promoter sequence exist in most of the tRNA species, the remaining residues must be generated by base substitutions, which might impair the suppressor activity of the tRNA. In fact, the suppressors derived from E.coli tRNA Tyr failed to exhibit suppressor activity in the presence of E.coli TyrRS. This dif®culty was overcome by utilizing the natural diversity in the tRNA sequences that can be recognized by an aaRS species; B.stearothermophilus suppressor tRNA Tyr , together with E.coli TyrRS, can cause amber suppression in mammalian cells.
It has been proposed that suppressor tRNAs that can work in mammalian cells are potential gene therapy agents for various human diseases associated with nonsense mutations (36, 37) . The possible toxicity due to a constitutive suppressor activity may be avoided by the use of an inducible suppression system depending on a tRNA´aaRS pair orthogonal to the mammalian translation system (35) . The present study developed a second orthogonal tRNA´aaRS pair functional in mammalian cells. The inducible suppression systems may also be useful for the conditional gene expression required in cell biology studies (38) .
Orthogonal tRNA´aaRS pairs are also useful for alloprotein synthesis in living cells, when the aaRS is engineered to be speci®c for an unnatural amino acid. The genetic code of E.coli has thus been engineered so that tyrosine analogs, assimilated from the growth medium, can be incorporated at the amber positions of proteins (17, 18) . The present study showed that this approach can be extended to a living eukaryotic system; 3-iodo-L-tyrosine in the growth medium, which also contained L-tyrosine at a 2-fold higher concentration, was actually taken up by the cell and almost exclusively occupied the amber position in the proteins. Although TyrRS(V37C195) expressed from the plasmid incorporates L-tyrosine in the absence of 3-iodo-L-tyrosine, we found that inducible expression of the variant enzyme signi®cantly decreases the level of tyrosine incorporation. Although the feasibility of aaRS engineering has been demonstrated with M.jannaschii and E.coli TyrRSs (17±19), its scope remains to be expanded to include unnatural amino acids that are largely different from the canonical amino acids in their chemical or structural characteristics.
The mammalian system developed in the present study is advantageous for the incorporation of 3-iodo-L-tyrosine into eukaryotic proteins, because some of them are not properly folded into their native conformations in prokaryotic systems. 3-Iodo-L-tyrosine incorporation allows 125 I-labeling of proteins for tracing them in cell fractions and may be useful for the X-ray crystallographic analysis of proteins. A phosphorylated 3-iodo-L-tyrosine residue in a peptide is selectively accepted by an engineered Src homology 2 (SH2) domain, but not by the wild-type SH2 domain (manuscript in preparation). Thus, 3-iodo-L-tyrosines inserted within cellular signaling proteins may be utilized to modulate communication between the proteins. In thyroglobulins, the precursors of thyroid hormones, 3-iodo-L-tyosine residues exist naturally, due to post-translational modi®cation. Thus, the genetic assignment of unnatural amino acids will provide a useful tool for regulating the post-translational modi®cation of mammalian proteins. 
